esc semaglutide in HFpEF and Obesity, Role of SGLT2 Inhibitors to Highlight 2023 ESC 2025: evidence of semaglutide
Description
It includes a section for weekly habits and goals, with circles to mark progress or completion
The new craze of using lower-than-recommended dosages of weight loss drugs to slim down might sound tempting, says Charlotte Cripps, but counting the clicks is no way to live
GLP-1 receptor agonist drugs protect against diabetic retinopathy, a common complication of diabetes that can lead to sight loss, suggests new research being presented at the annual meeting
Additionally, these agents may mitigate cardiovascular risks and improve outcomes in patients with conditions like polycystic ovary syndrome (PCOS)
Learn how medications like Ozempic and Wegovy affect gastric emptying, what clinical evidence shows about GERD risk, and practical strategies to manage reflux symptoms during treatment.
February 10, 2024
